Literature DB >> 18669158

Cutting edge: the vaginal microflora and bacterial vaginosis.

H Verstraelen1.   

Abstract

Under physiological conditions, the vaginal primarily harbours lactobacilli which ideally confer in mutualism with the vaginal epithelium colonisation resistance to other micro-organisms, thereby preventing ascending or systemic infection. Albeit only a few Lactobacillus species constitute the vaginal microflora, huge species- and strain-specific differences occur however, and these differences account for a wide variability in the intrinsic capability of the Lactobacillus microflora to maintain the vaginal ecosystem. Hence, among a substantial proportion of women, the picture of lactobacilli-driven mutualism is actually less ideal than one may assume. As the vagina is incessantly subjected to cyclic changes as well as behavioural exposures that may challenge the perpetuation of the Lactobacillus microflora, the intrinsic stability of the resident microflora is paramount to women's health. Considering the close concordance between the rectal and vaginal lactobacilli, future research may benefit from the study of food, oral, and intestinal microbiology in relation to the vaginal Lactobacillus microbiota. Loss of the hydrogen peroxide producing lactobacilli accompanied by massive anaerobic overgrowth is observed with bacterial vaginosis. Molecular studies of the bacterial vaginosis microflora have recently revealed a tremendous species variability further documenting the complex polymicrobial nature of this condition. Emerging issues include the predominance of G. vaginalis, a normal microflora constituent possibly eliciting a host of virulence mechanisms at increasing concentrations through quorum sensing, the associated abundance of A. vaginae as a rather specific marker of therapy failure and disease persistence or recurrence, and the discovery of an adherent, metronidazole-resistant biofilm consisting of the latter two species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669158

Source DB:  PubMed          Journal:  Verh K Acad Geneeskd Belg        ISSN: 0302-6469


  6 in total

1.  Heterogeneity of vaginal microbial communities within individuals.

Authors:  Tae Kyung Kim; Susan M Thomas; Mengfei Ho; Shobha Sharma; Claudia I Reich; Jeremy A Frank; Kathleen M Yeater; Diana R Biggs; Noriko Nakamura; Rebecca Stumpf; Steven R Leigh; Richard I Tapping; Steven R Blanke; James M Slauch; H Rex Gaskins; Jon S Weisbaum; Gary J Olsen; Lois L Hoyer; Brenda A Wilson
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

2.  Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli--an in vitro study.

Authors:  Pamela Hasslöf; Maria Hedberg; Svante Twetman; Christina Stecksén-Blicks
Journal:  BMC Oral Health       Date:  2010-07-02       Impact factor: 2.757

3.  Antagonistic Action of Lactobacilli and Bifidobacteria in Relation to Staphylococcus aureus and Their Influence on the Immune Response in Cases of Intravaginal Staphylococcosis in Mice.

Authors:  Liudmyla Lazarenko; Lidiia Babenko; Liubov Shynkarenko Sichel; Valentyn Pidgorskyi; Viktoriia Mokrozub; Olga Voronkova; Mykola Spivak
Journal:  Probiotics Antimicrob Proteins       Date:  2012-02-25       Impact factor: 4.609

4.  Probiotics, prebiotics, and synbiotics: gut and beyond.

Authors:  Usha Vyas; Natarajan Ranganathan
Journal:  Gastroenterol Res Pract       Date:  2012-09-19       Impact factor: 2.260

Review 5.  Genetic and functional profiling of Crohn's disease: autophagy mechanism and susceptibility to infectious diseases.

Authors:  Annalisa Marcuzzi; Anna Monica Bianco; Martina Girardelli; Alberto Tommasini; Stefano Martelossi; Lorenzo Monasta; Sergio Crovella
Journal:  Biomed Res Int       Date:  2013-05-08       Impact factor: 3.411

6.  Transcriptome Profiling Analysis of Bovine Vaginal Epithelial Cell Response to an Isolated Lactobacillus Strain.

Authors:  Chunyu Niu; Chao Cheng; Yanmin Liu; Shaolei Huang; Yanru Fu; Peifeng Li
Journal:  mSystems       Date:  2019-09-10       Impact factor: 6.496

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.